We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J, Teva Lose Last-Ditch Bids To Avoid Okla. Opioid Trial

Law360 (May 13, 2019, 7:36 PM EDT) -- An Oklahoma judge on Monday swatted down eleventh-hour efforts by Johnson & Johnson and Teva Pharmaceuticals to escape the state's trailblazing opioid-crisis lawsuit, clearing the way for a dramatic trial over liability for a deadly epidemic of painkiller abuse.

The three-page ruling by Judge Thad Balkman rejected motions for summary judgment from J&J and Teva without any explanation. The upshot is that no more barriers remain to stop a bench trial that's set to start on May 28, unless the drugmakers settle.

In a statement on Monday, Oklahoma Attorney General Mike Hunter said that his legal team is "prepared for May...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS